Key result
Recent advances in diagnostic methods, implantable devices, and antiarrhythmic agents have broadened the therapeutic options for patients with tachyarrhythmias.
Recent advances in diagnostic methods, implantable devices, and antiarrhythmic drugs have broadened the management options for patients with tachyarrhythmias.
Answers are grounded in this paper and cite their sources.
May inform evolving tachyarrhythmia strategies; leaves open rigorous evaluation of new modalities in randomized settings.
Recent developments of both diagnostic and therapeu tic techniques in the management of tachyarrhythmias have broadened the options available to physicians car ing for patients with tachyarrhythmias. Newer diag nostic methods allow more precise identification of the arrhythmia and better understanding of its mechanism. Long-term epidemiologic studies have identified groups of patients who do and do not require antiarrhythmic therapy. Antitachycardia pacemakers and automatic im plantable defibrillators allow effective treatment for pa tients for whom drugs were ineffective or in whom in tolerable side effects developed. Finally, several new antiarrhythmic agents have become available recently. Proper use of these new techniques and drugs requires greater understanding of the pathophysiology of cardiac arrhythmias.
No takes yet. Share an insight, caveat, or question.
John M. Herre (1987) conducted a review in Tachyarrhythmias. Diagnostic and therapeutic techniques (pacemakers, defibrillators, antiarrhythmic agents) was evaluated. Recent advances in diagnostic methods, implantable devices, and antiarrhythmic agents have broadened the therapeutic options for patients with tachyarrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: